Literature DB >> 1757121

Lymphocyte blastogenic responses in sickle cell disease.

S Taylor1, S Shacks, S Villicana, J Olivares, G Dinkins.   

Abstract

Cell mediated immunity (CMI) has not been extensively studied in sickle cell disease (SCD). In this study, an assessment of lymphocyte blastogenic responses was done in 62 SCD patients (62 steady state and 25 in crisis with or without documented infection), along with 30 normal controls in good health and 10 with various infections. The mitogen phytohemagglutinin (PHA) and two antigens (Candida albicans and Tetanus Toxoid) were used as stimuli. An evaluation of these results by stimulation index revealed 53/62 (86%) of SCD steady state patients, 30/30 (100%) of healthy controls and 7/10 (70%) of normal control patients with infection positively responded to all three stimuli. Conversely, only 5/25 (20%) of SCD crisis state patients had totally normal blastogenic responses. Analysis of the data from SCD crisis patients revealed 14/20 (70%) with abnormally depressed proliferation to PHA, 11/20 (55%) to Candida and 6/20 (30%) to Tetanus. When comparisons were made by mean counts per minute, the most striking finding was the PHA response in the SCD crisis state. In this group the mean counts per minute were significantly less than the three other groups by statistical analysis. This data suggests that the crisis state, especially when associated with infection, profoundly effects blastogenic responses to PHA and to a lesser degree in vitro antigenic stimulation. The normal group with infection showed similar diminished blastogenesis to antigen, but no effect on mitogen response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757121     DOI: 10.3109/08820139109026244

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  4 in total

1.  In vivo production of type 1 cytokines in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu
Journal:  J Natl Med Assoc       Date:  1999-11       Impact factor: 1.798

2.  Type 2 cytokine serum levels in healthy sickle cell disease patients.

Authors:  S C Taylor; S J Shacks; Z Qu; P Wiley
Journal:  J Natl Med Assoc       Date:  1997-11       Impact factor: 1.798

3.  Combined effects of in vitro penicillin and sickle cell disease sera on normal lymphocyte functions.

Authors:  Stephen C Taylor; Samuel J Shacks; Zengwei Qu; Psyhra Bryant
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

4.  In Vitro Lymphocyte Functions in Undernourished Children With Sickle Cell Anemia.

Authors:  Solo R Kuvibidila; Renée Gardner; Maria C Velez; Lolie Yu; Rajasekharan P Warrier
Journal:  Ochsner J       Date:  2020
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.